Form 4 Filing for Perriman Damien Alan

This Form 4 filing details a transaction by Perriman Damien Alan, Chief Commercial Officer of EXOZYMES INC. (EXOZ). On April 1, 2026, Mr. Perriman acquired 8,887 shares of common stock at a price of $8.44 per share. This transaction is marked with code "A" for acquisition. Following this transaction, the reported post-transaction shares owned are 0. The filing was signed on April 7, 2026.